FOLD vs NVS
Amicus Therapeutics Inc (FOLD) versus NVS (NVS) — a side-by-side from cached financials, not a winner call.
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
NVS (NVS) common stock.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
NVS does not have a complete income-statement cache yet.
FOLD currently screens at market cap $1.80B. NVS currently screens at market cap $0.
Not investment advice. Open the FOLD and NVS stock pages for the full models.
Not investment advice.